Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
Bulletin of the World Health Organization|January 15, 2009
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretroviralsMacarthur Charles, Francine Noel, Paul Leger, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2026
A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)John R Koethe, Jordan E Lake, Amy Kantor, et al.
Plos One|May 30, 2009
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivoAthe M N Tsibris, Bette Korber, Ramy Arnaout, et al.
The New England Journal of Medicine|October 4, 2008
Maraviroc for previously treated patients with R5 HIV-1 infectionRoy M Gulick, Jacob Lalezari, James Goodrich, et al.
Open Forum Infectious Diseases|July 10, 2024
Long-acting HIV Treatments: Study Design, Logistics, and AccessNicholas A Murdock, Nayri E Alajaji, Robin Schaefer, et al.
The Journal of Infectious Diseases|September 22, 2017
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials ParticipantsKatie R Mollan, Camlin Tierney, Jacklyn N Hellwege, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211Athe M N Tsibris, Roger Paredes, Amy Chadburn, et al.
JAMA|August 15, 2006
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trialRoy M Gulick, Heather J Ribaudo, Cecilia M Shikuma, et al.
The New England Journal of Medicine|April 30, 2004
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infectionRoy M Gulick, Heather J Ribaudo, Cecilia M Shikuma, et al.
Pageof 21